Restylane
Manufacturing · Canada · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
Hazelton Ave, Toronto, Ontario, CanadaPhone Number
+46 184749000Website
www.restylaneusa.comRevenue
$185.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Restylane
Restylane is produced by Galderma, a global company, committed to delivering innovative medical solutions to meet the dermatological needs of people throughout their lifetime while serving healthcare professionals around the world. The site in Uppsala, Sweden, where Restylane is produced is Galderma's Global Center of Excellence for Aesthetic and Corrective solutions with state-of-the-art research, development and manufacturing facilities. After over a decade of clinical use, over 20 million treatments* worldwide with continuous research and safety as top priority, Restylane has been proven to be safe, effective and long-lasting. Galderma continues to invest in a research and development, in the interest of improving further patient safety and new product development. Our UK office is based in Watford, Hertfordshire.Explore more
Restylane Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Restylane your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Restylane is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Restylane
Earning: See what the market has to say on Restylane recently announced quarterly report
Funding: Get notified immidiatlly once Restylane has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Restylane has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Restylane launches new products
Website visits: Recent activity has been detected on your website
Click to see if Restylane had a recent Job posting/layoffs
Restylane, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Restylane as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Restylane is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Restylane is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Restylane.
Restylane Tech Stack
A closer look at the technologies used by Restylane
Restylane News & Media
GALDERMA RECEIVES FDA APPROVAL FOR ITS NEWEST HYALURONIC ACID FILLER, RESTYLANE® EYELIGHT
Restylane Eyelight is the first and only product in the U.S. to use NASHA® Technology to improve the appearance of undereye hollows for up to 18 months1 DALLAS, June 5, 2023 /PRNewswire/ -- Galderma announced today the U.S. Food and Drug Administration (FDA) approved Restylane® Eyelight...RESTYLANE® celebrates 25 years of natural-looking results with its signature line of hyaluronic acid fillers
FORT WORTH, Texas, Sept. 30, 2021 /PRNewswire/ -- Galderma, the world's largest independent dermatology company, today marks the 25th anniversary of RESTYLANE®. Since launching in Europe in 1996 and becoming the first hyaluronic acid filler approved by the U.S. Food and Drug...Galderma Receives FDA Approval for Restylane® Contour for Cheek Augmentation and Correction of Midface Contour Deficiencies
FORT WORTH, Texas, June 29, 2021 /PRNewswire/ -- Galderma announced today the U.S. Food and Drug Administration (FDA) has approved Restylane® Contour for cheek augmentation and correction of midface contour deficiencies in adults over the age of 21.1 Restylane Contour, a new hyaluronic...Galderma Receives FDA Approval for Restylane® Defyne for Chin Augmentation
FORT WORTH, Texas, Feb. 1, 2021 /PRNewswire/ -- Galderma announces that the U.S. Food and Drug Administration (FDA) has approved Restylane® Defyne for the augmentation and correction of mild to moderate chin retrusion for adults over the age of 21.1 In 2020 alone, online searches for chin...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Restylane
Sign Up For FreeTo access detailed company insights
Restylane is produced by Galderma, a global company, committed to delivering innovative medical solutions to meet the dermatological needs of people throughout their lifetime while serving healthcare professionals around the world. The site in Uppsala, Sweden, where Restylane is produced is Galderma's Global Center of Excellence for Aesthetic and C... Read More
